Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | REGN | ARGX | ||
| Company | Csl Ltd ADR | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 24.2745 | 756.65 | 695.89 | ||
| High | 24.4600 | 759.47 | 705.66 | ||
| Low | 24.1195 | 736.64 | 690.85 | ||
| Latest | 24.3400 | 737.71 | 691.40 | ||
| Change | +0.2800 | -19.02 | -1.43 | ||
| % Change | +1.16% | -2.51% | -0.21% | ||
| Volume | 946,900 | 492,100 | 418,900 | ||
| 20-Day Average Volume | 606,010 | 600,345 | 356,435 | ||
| Previous Close | 24.0600 | 756.73 | 692.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.8737 | 757.15 | 710.23 | ||
| 20-Day Raw Stochastic | 29.21% | 14.70% | 28.32% | ||
| 20-Day Relative Strength | 38.88 | 44.87 | 36.48 | ||
| Weighted Alpha | -42.14 | +21.64 | +7.94 | ||
| Today's Opinion | 100% Sell | 24% Buy | 72% Sell | ||
| Previous Opinion | 100% Sell | 40% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.59% since 03/20/26 | +0.66% since 03/20/26 | +4.14% since 03/20/26 | ||
| Low | 23.9200 on 03/26/26 | 727.96 on 03/24/26 | 666.79 on 03/24/26 | ||
| High | 25.3100 on 03/23/26 | 761.73 on 03/26/26 | 705.66 on 03/27/26 | ||
| 1-Month | |||||
| %Chg | -6.58% since 02/27/26 | -5.62% since 02/27/26 | -9.85% since 02/27/26 | ||
| Low | 22.8300 on 03/19/26 | 727.88 on 03/19/26 | 661.85 on 03/20/26 | ||
| High | 28.0000 on 03/02/26 | 794.77 on 03/03/26 | 766.19 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -16.50% since 12/26/25 | -6.02% since 12/26/25 | -18.17% since 12/26/25 | ||
| Low | 22.8300 on 03/19/26 | 718.38 on 01/20/26 | 661.85 on 03/20/26 | ||
| High | 33.5316 on 02/10/26 | 821.11 on 01/09/26 | 881.89 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | -24.02% since 09/26/25 | +30.82% since 09/26/25 | -2.84% since 09/26/25 | ||
| Low | 22.8300 on 03/19/26 | 541.00 on 10/13/25 | 661.85 on 03/20/26 | ||
| High | 36.2850 on 10/22/25 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 47,250,660 | 77,990,704 | 42,785,900 | ||
| Shares Outstanding, K | 1,941,276 | 105,720 | 61,883 | ||
| Annual Sales | 15,558,000,000 | 14,342,900,000 | 4,248,050,000 | ||
| Annual Net Income | 3,002,000,000 | 4,504,900,000 | 1,292,040,000 | ||
| Last Quarter Sales | N/A | 3,884,300,000 | 1,322,160,000 | ||
| Last Quarter Net Income | N/A | 844,600,000 | 532,950,000 | ||
| 60-Month Beta | 0.80 | 0.41 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 11.44 on 01/30/26 | 8.02 on 02/26/26 | ||
| Latest Earnings Date | 08/19/25 | 04/29/26 | 05/14/26 | ||
| Most Recent Dividend | 0.300 on 03/11/26 | 0.940 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | 03/11/26 | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.97 | 35.49 | ||